Table 2 Quality of Life (QoL) of Brain Tumor Patients as measured by the EORCT QLQ-C30 and QL-BN20
QLQ-C30 Component | Mean (SD) |
|---|---|
Global QoL | 75.73 (14.9) |
Functional scale | |
Physical functioning | 81.65(21.45) |
Role functioning | 81.20 (33.02) |
Emotional functioning | 86.07 (13.34) |
Cognitive functional | 84.53 (20.39) |
Social functional | 87.93 (21.01) |
Symptom scales | |
Fatigue | 9.55 (11.95) |
Nausea | 9.20 (15.00) |
Pain | 29.70 (30.48) |
Dyspnea | 4.66 (14.02) |
Insomnia | 25.06 (25.40) |
Appetite loss | 26.13 (26.40) |
Constipation | 2.13 (9.20) |
Diarrhea | 11.46 (22.59) |
Financial difficulties | 21.06 (32.59) |
QLQ-BN20 component | Mean (SD) |
|---|---|
Symptom scale | |
Future uncertainty | 7.53 (14.32) |
Visual disorder | 8.16 (15.30) |
Motor symptoms | 11.46 (17.15) |
Communication deficit | 9.33 (16.38) |
Headache | 21.46 (25.46) |
Seizures | 2.93 (11.96) |
Drowsiness | 10.13 (21.00) |
Hair loss | 10.53 (21.12) |
Itchy skin | 7.33 (17.27) |
Weakness | 18.40 (25.33) |
Bladder control | 5.86 (17.45) |